… Metastatic gastric cancer remains a non-curative disease. Palliative chemotherapy has …
For patients with localized disease, the role of adjuvant and neoadjuvant chemotherapy and …

… of chemotherapy for gastric cancer related to indication and modc of administration. …
Chemotherapy for gastric cancer has been givcn under different circumstances and by different …

… with gastric cancer up-regulation of survivin (BIRC5) has been associated with a poorer … -5
in gastric cancer, the advances made in the prediction of the failure of chemotherapy, and the …

… Chemotherapy is indispensable for gastric cancer. For unresectable and/or recurrent gastric
cancer, first-line chemotherapy … Second- and third-line chemotherapy regimens include …

… of all people with advanced gastric cancer since all people with advanced gastric cancer
must now undergo HER‐2 testing before the initiation of any chemotherapy and, in the absence …

… Gastric cancer (GC) has ranked as the fifth most common cancer and the third leading
cause of cancer mortality worldwide in 2018 [1]. Eastern Asia has been identified as the region …

… In summary, in assessing results of trials of neoadjuvant chemotherapy in gastric cancer,
one has to take in mind that patients with potentially resectable tumors at the time of study entry …

… or recurrent gastric cancer, systemic chemotherapy has become … However, new chemotherapy
regimens, including newer … perspectives for chemotherapy for metastatic gastric cancer, …

… A systematic review of chemotherapy trials in several tumour … the literature on chemotherapy
in the treatment of gastric cancer is … chemotherapy as routine treatment in the Western world. …

… in which 217 Canadian oncologists were asked about chemotherapy treatment of advanced
gastric cancer, only 41% considered chemotherapy prolonged these patient’s survival and …